Breaking Barriers in Gene Therapy: Miquel Vila-Perello's Vision for Curing Untreatable Diseases
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Miquel Vila-Perello, co-founder and CEO of Splice Bio, a gene therapy company focused on treating Stargardt disease. They discuss Miquel's journey from academia to biotech, the challenges of fundraising, the importance of passion and resilience in drug development, and the future of gene therapy. Miquel shares insights on balancing rationality and passion, the differences between academic and industry research, and the significance of building trust with investors.
Related Insights
CTB Podcast
Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets
Aug 11, 2025
CTB Podcast
The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
Jul 14, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
CTB Podcast
Introducing Clinical Trialblazers!
Mar 6, 2025
Related Insights
CTB Podcast
Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets
Aug 11, 2025
CTB Podcast
The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto
Jul 14, 2025
CTB Podcast
Leading with Science and Heart: Building a Resilient Biotech
Jun 9, 2025
CTB Podcast
Bedside to Biotech: Building Trust, Storytelling in Science, and Pediatric Cancer Innovation
May 12, 2025
CTB Podcast
From Mentee to CEO, Board Member and Mentor
Apr 17, 2025
CTB Podcast
Leading through setbacks with Cytokinetics
Mar 26, 2025